PDCD1 and melanoma: Recently, Oster P et al. found that in mice engrafted with MC38 colon adenocarcinoma or B16-OVA melanoma cells, the tumor volumes of noninfected mice undergoing anti-CTLA4 and/or PD-1 or anticancer vaccine treatments were significantly smaller than those of infected mice.